cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Regenxbio Inc
4 own
3 watching
Current Price
$15.69
$-0.42
(-2.61%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
783.98M
52-Week High
52-Week High
28.80000
52-Week Low
52-Week Low
11.83000
Average Volume
Average Volume
0.57M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
44.65
iconMarket Capitalization783.98M
icon52-Week High28.80000
icon52-Week Low11.83000
iconAverage Volume0.57M
iconDividend Yield--
iconP/E Ratio44.65
What does the Regenxbio Inc do?
Developing gene therapies for rare diseases with a proprietary delivery platform.
Read More
How much money does Regenxbio Inc make?
News & Events about Regenxbio Inc.
Market News Video
1 year ago
In trading on Wednesday, shares of REGENXBIO Inc (RGNX) crossed above their 200 day moving average of 24.76, changing hands as high as 25.27 per share. REGENXBIO Inc shares are currently trading up about 13.6% on the day...
PR Newswire
1 year ago
Additional Positive Interim Data from Phase I/II Trial of REGENXBIO'S RGX-111 for the Treatment of Severe MPS I Presented at WORLDSymposium Additional Positive Interim Data from Phase I/II Trial of REGENXBIO'S RGX-111 for the Treatment of Severe MPS I Presented at WORLDSymposium PR Newswire...
PR Newswire
1 year ago
REGENXBIO Announces Presentations at the 19th Annual WORLDSymposium 2023 REGENXBIO Announces Presentations at the 19th Annual WORLDSymposium 2023 PR Newswire ROCKVILLE, Md., Feb. 17, 2023 New interim data from Phase I/I/III trial of RGX-121 for the treatment of MPS II and Phase I/II trial of...
PR Newswire
1 year ago
REGENXBIO Presents Interim Data from Phase II Bridging Study Evaluating the Clinical Performance of RGX-314 Using the NAVXpress Manufacturing Platform Process REGENXBIO Presents Interim Data from Phase II Bridging Study Evaluating the Clinical Performance of RGX-314 Using the NAVXpress...
PR Newswire
1 year ago
REGENXBIO Announces Presentations at the Angiogenesis, Exudation, and Degeneration 2023 Conference REGENXBIO Announces Presentations at the Angiogenesis, Exudation, and Degeneration 2023 Conference PR Newswire ROCKVILLE, Md., Feb. 6, 2023 ROCKVILLE, Md., Feb. 6, 2023 /PRNewswire/ -- REGENXBIO Inc...
Frequently Asked Questions
Frequently Asked Questions
What is Regenxbio Inc share price today?
plus_minus_icon
Can Indians buy Regenxbio Inc shares?
plus_minus_icon
How can I buy Regenxbio Inc shares from India?
plus_minus_icon
Can Fractional shares of Regenxbio Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Regenxbio Inc stocks?
plus_minus_icon
What is today’s traded volume of Regenxbio Inc?
plus_minus_icon
What is today’s market capitalisation of Regenxbio Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Regenxbio Inc?
plus_minus_icon
What percentage is Regenxbio Inc down from its 52-Week High?
plus_minus_icon
What percentage is Regenxbio Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$15.69
$-0.42
(-2.61%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00